# MediCare Phase 27 Final Completion Audit

**Final status:** `PROJECT FUNCTIONALLY COMPLETE — PRODUCTION DEPLOYMENT PENDING`  
**Clinical status:** `EXTERNAL DEPENDENCY — CLINICAL VALIDATION REQUIRED`  
**Phase:** 27 — Final SRS Gap Closure, Clinical Validation Preparation, and Deployment Readiness  
**Author:** Manus AI  
**Date:** 15 August 2026  
**Source of truth:** Restored and verified `medicare_phase26_completed.zip`

## 1. Executive summary

Phase 27 is complete as a final audit/readiness phase. The attached Phase 26 package was verified, restored without reconstruction, and re-audited against all retained project-authored SRS/specification sources and the current implementation. The original external SRS document was not present in the package, so no missing requirements were invented and no percentage-complete claim was made.

The audit found no additional runtime feature that could be safely and honestly implemented in the sandbox without an approved workflow, clinical policy, external data, production infrastructure, or legal/privacy decision. Phase 27 therefore closed the supported work through current-state traceability, clinical-validation preparation, model-governance confirmation, security/privacy readiness review, deployment-readiness documentation, and reproducible final-readiness scanning. No model, AI authorization, patient ownership boundary, or Phase 26 clinical workflow was changed.

## 2. Current project status

The project is **functionally complete for the bounded patient, doctor, Admin, clinical, and academic-AI requirements retained and implemented through Phases 1–26**. It is not a clinically validated system, not a regulatory approval, and not a production deployment. PostgreSQL, HTTPS, durable storage, backup/restore, monitoring, rollback, independent security testing, accessibility testing, and clinical validation remain external dependencies.

The current-state matrix contains **59 identifiable retained requirement rows**: 47 complete, 6 partial, 0 not implemented, 2 deferred, 3 blocked, and 0 not applicable. These are counts of retained project-authored requirements, not a percentage of the unavailable original SRS.

## 3. SRS completion matrix

| Status | Count | Interpretation |
|---|---:|---|
| Complete | 47 | Current source and evidence satisfy the bounded retained requirement |
| Partial | 6 | A technical foundation exists, but production, clinical, accessibility, or operational evidence remains |
| Not implemented | 0 | No retained requirement was identified that is both required and simply missing from the current bounded scope |
| Deferred | 2 | Deliberately excluded pending approved Admin privacy or operational lifecycle policy |
| Blocked | 3 | External source, clinical cohort, PostgreSQL, or retention policy is unavailable |
| Not applicable | 0 | No retained requirement was classified as not applicable |
| **Total** | **59** | Reconciled current-state matrix count |

The full row-level traceability is in [`MEDICARE_FINAL_SRS_TRACEABILITY.md`](MEDICARE_FINAL_SRS_TRACEABILITY.md), and the current-source audit table is in [`MEDICARE_PHASE_27_CURRENT_REQUIREMENT_MATRIX.md`](MEDICARE_PHASE_27_CURRENT_REQUIREMENT_MATRIX.md).

## 4. Completed functionality

The verified project contains session-based registration/login/logout, role boundaries, patient profiles, patient appointment workflows, doctor appointment workflows, Admin patient/doctor/appointment management, patient-owned read-only clinical records/reports/prescriptions, protected clinical files, appointment-authorized doctor clinical access, Phase 26 doctor create actions for records/reports/prescriptions, safe-DOM clinical rendering, the single authorized academic AI endpoint, native model-tied XAI, doctor-owned AI reports, minimized immutable AI audit events, and aggregate Admin AI audit access.

The Phase 26 clinical workflow remains explicit and doctor-triggered. It does not infer diagnoses, recommend treatment, change prescriptions autonomously, notify patients, or execute emergency actions.

## 5. Remaining functionality

Remaining requirements are not arbitrary missing healthcare features. They are bounded external or policy-dependent items: a clinical record amendment/version lifecycle, patient refill-request workflow, detailed Admin clinical access if ever authorized, production data retention/deletion/archival rules, production backup/restore, monitoring/incident response, PostgreSQL deployment, independent security/accessibility assessment, and genuine clinical validation.

No additional patient write, unrestricted Admin detail, clinical recommendation, or AI capability was implemented because the current retained requirements do not safely authorize it.

## 6. AI status

The AI capability remains one academic/development-only binary classification workflow around the existing Logistic Regression artifact:

```text
Model: uci-heart-disease-logreg-v1.0.0
Endpoint: POST /api/ai/heart-risk/predict/
SHA-256: e548527e51c67a7b611501acc844b367cecdde53413e33914ed9757fb9bae6cd
```

The model uses the documented UCI Heart Disease Cleveland processed dataset provenance, feature schema, target transformation, training configuration, preprocessing pipeline, evaluation metrics, and native coefficient explanation. The probability remains **not diagnostic confidence**. The AI remains **academic/development-only** and **not clinically validated**.

Phase 27 did not retrain, refit, re-export, convert, replace, expose, or otherwise modify the model artifact. Exactly one AI route remains. Patient AI denial remains intact. No chatbot, RAG, LLM, external provider, autonomous diagnosis, treatment recommendation, medication recommendation, emergency decision, or autonomous patient action was added.

## 7. Clinical-validation status

Clinical validation was not performed and is not claimed. The exact external requirements are documented in [`PHASE27_CLINICAL_VALIDATION_READINESS.md`](PHASE27_CLINICAL_VALIDATION_READINESS.md). They include an approved representative validation cohort, prespecified inclusion/exclusion criteria, clinically meaningful target and reference standard, independent cohort, performance and uncertainty evaluation, subgroup/fairness analysis, calibration, external validation, clinical review, governance/legal approval, monitoring, incident handling, and change control.

The UCI development dataset and its held-out metrics do not establish clinical validity. Real patient data was not accessed.

## 8. Security status

The current application preserves session authentication, server-side role authorization, appointment/object authorization, CSRF protection, safe serialization, ORM-based query construction, XSS-safe clinical/AI rendering, protected file validation/downloads, bounded error responses, safe logging, audit/report minimization, dependency pinning, and model checksum verification.

The Phase 22, Phase 24, Phase 25, Phase 26, and Phase 27 static security/readiness scans are evidence of code-level controls within the audited scope. They are not a substitute for an independent production penetration test, DAST/SAST review, threat model, dependency-vulnerability program, or incident-response exercise.

## 9. Privacy status

Patient clinical list ownership, cross-patient isolation, doctor appointment authorization, Admin minimum-necessary AI aggregate access, patient AI denial, no raw prediction-history exposure to patients, no browser persistence of clinical/prediction data, and protected-file access controls remain preserved.

The remaining privacy dependency is an approved retention/deletion/archival policy for clinical records, uploaded files, prediction reports, AI audit events, accounts, logs, backups, and model/evaluation artifacts. The project governance document requires such rules but does not define a legal period. Phase 27 does not invent one.

## 10. Deployment readiness

The source includes production fail-closed configuration for secret key, `DEBUG`, hosts, frontend origins, secure cookies, HTTPS redirect, HSTS, content-type nosniff, and same-origin referrer policy. Backend dependencies are exact-pinned, and PostgreSQL configuration hooks and a local setup guide are present.

This is **deployment preparation**, not deployment. The exact procedures and remaining controls are documented in [`PHASE27_DEPLOYMENT_READINESS.md`](PHASE27_DEPLOYMENT_READINESS.md).

## 11. PostgreSQL limitation

PostgreSQL was not installed, accessed, or validated from the Ubuntu sandbox. The user’s Windows PostgreSQL was not accessed. The project was validated with disposable SQLite test databases only. The deployment guide specifies PostgreSQL 18.6-style local configuration, application role/database setup, environment variables, connection verification, migrations, and regression steps for execution by the user or deployment owner in the actual target environment.

Therefore, the final status is not production complete and does not claim PostgreSQL readiness beyond source/configuration preparation.

## 12. Production-environment limitation

No production domain, TLS termination, reverse proxy, WSGI/ASGI service, PostgreSQL server, durable protected-media store, secret manager, backup service, monitoring platform, alert route, incident system, on-call owner, rollback environment, or load-test environment was available. No production migration, static collection, protected-media restore, backup restore, rollback, or HTTPS smoke test was executed.

## 13. Remaining external approvals

Before any clinical use or production deployment, the responsible owner must obtain the appropriate clinical, privacy, security, legal/regulatory, data-governance, accessibility, infrastructure, and operational approvals. These approvals must define intended use, prohibited use, validation cohort, reference standard, retention, user roles, monitoring, incident handling, model change control, deployment ownership, and rollback authority.

## 14. Remaining technical work

The remaining technical work is environment-specific rather than safely implementable in this sandbox: provision PostgreSQL, configure production secrets, deploy HTTPS and static/protected-media serving, run reviewed migrations, conduct independent security/accessibility testing, configure backups and restore drills, establish monitoring and alerts, perform load/performance tests, verify model checksum in the deployment pipeline, and rehearse rollback.

If clinical validation is approved, a separately governed model version and artifact checksum may be required after the validation decision. Phase 27 intentionally does not alter the current artifact.

## 15. Recommended future phase

No Phase 28 was started or automatically scheduled. If future work is authorized, it should begin only after the original SRS is supplied or formally re-approved, and should be a separately governed external-dependency phase focused on PostgreSQL/production deployment and/or clinical validation—not an arbitrary feature phase.

## 16. Exact model checksum

The final required identity is:

| Model | SHA-256 |
|---|---|
| `uci-heart-disease-logreg-v1.0.0` | `e548527e51c67a7b611501acc844b367cecdde53413e33914ed9757fb9bae6cd` |

The checksum matched the restored package artifact before and after Phase 27 documentation/scanner changes.

## 17. Test evidence

The restored Phase 26 baseline passed before Phase 27 changes:

| Validation | Actual result |
|---|---|
| Django system check | PASS; no issues |
| Migration check | PASS; no changes detected |
| Full Django suite | PASS; 40/40 tests |
| Phase 26 focused suite | PASS; 6/6 tests |
| Phase 22 security scan | PASS; all checks true |
| Phase 24 security scan | PASS; all checks true |
| Phase 25 security scan | PASS; all checks true |
| Phase 26 security scan | PASS; all checks true |
| Model checksum | PASS; expected SHA-256 |
| Phase 19/20/23/24/25/26 frontend contracts | PASS |
| JavaScript syntax | PASS |
| Python compilation | PASS |

Phase 27 added and passed the final readiness scanner, frontend-reference validator, matrix reconciliation, and the same regression/security/frontend/integrity suite after documentation changes. No previous test was removed or weakened.

## 18. Browser evidence

Phase 26 synthetic browser evidence retained in the source package verified doctor login, dashboard, authorized clinical modal, appointment linking, record/report/prescription creation, patient prescription visibility, patient direct doctor-create denial (`403`), and logout redirect/session invalidation. Phase 27 performed a final synthetic smoke pass against the restored package without real patient data, using the existing Phase 26 seed/proxy helpers only where needed.

The final Phase 27 synthetic browser pass verified patient login/dashboard/clinical pages, patient AI denial and logout, doctor login/dashboard/AI/XAI/report access, appointment-scoped clinical workflow, final server persistence of a record/report/prescription owned by the synthetic doctor, Admin login/management/appointment oversight, aggregate AI audit access, detailed clinical-create denial, and Admin logout. The first record click did not persist an object; a controlled retry through the real form handler succeeded, and no source code was changed. Browser evidence is limited to sandbox-local synthetic workflows. It does not establish production operation, PostgreSQL behavior, clinical validity, regulatory compliance, or real-patient safety.

## 19. Final package contents

The Phase 27 package preserves the complete `medicare_phase2/` hierarchy and includes backend, frontend, AI/model artifacts, docs, migrations, the Phase 18 endpoint, Phase 23 XAI, Phase 24 clinical files, Phase 25 reporting/audit, Phase 26 clinical workflow, Phase 27 matrix/readiness documents, final traceability, final audit, final readiness scanner, frontend-reference validator, and final validation evidence.

It excludes virtual environments, Python caches, compiled files, runtime SQLite, protected-media smoke files, secrets, real patient data, and the Git directory. Archive integrity, required paths, exclusions, model checksum, and one-AI-route scope were validated after package creation.

## 20. Final project-completion decision

**Decision:** `PROJECT FUNCTIONALLY COMPLETE — PRODUCTION DEPLOYMENT PENDING`.

This is the strongest evidence-based status supported by the current source and available environment. The project is not honestly `PROJECT COMPLETE` for clinical or production use because clinical validation, PostgreSQL/production deployment, legal/privacy retention approval, independent security/accessibility review, backup/restore, monitoring, and rollback evidence remain external dependencies.

**Phase 27 is complete. Phase 28 was not started.**

## References

[1]: MEDICARE_PHASE_27_CURRENT_REQUIREMENT_MATRIX.md "Phase 27 current requirement matrix"

[2]: MEDICARE_FINAL_SRS_TRACEABILITY.md "Phase 27 final SRS traceability"

[3]: PHASE27_CLINICAL_VALIDATION_READINESS.md "Phase 27 clinical-validation readiness"

[4]: PHASE27_DEPLOYMENT_READINESS.md "Phase 27 deployment readiness"

[5]: ../ai/models/MODEL_CARD.md "MediCare academic model card"

[6]: ../docs/AI_DATA_GOVERNANCE.md "MediCare AI data governance"
